Publications by authors named "Reiko Fukui"

Claim this Profile
R
Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi

Breast Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers.
Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi

Breast Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Hiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, Ayako Bun, Reiko Fukui

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Haruka Kanaoka, Masayuki Nagahashi, Yusa Atake, Akira Hattori, Ayako Bun, Reiko Fukui

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin.
Atsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, Ayako Bun, Hiromi Ozawa

Anticancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Ayako Bun, Yukie Fujimoto, Tomoko Higuchi, Atsushi Sata, Reiko Fukui

Anticancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.
Reiko Fukui, Yukie Fujimoto, Takahiro Watanabe, Natsuko Inoue, Ayako Bun

Anticancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Reiko Fukui

Oncotarget· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Yukie Fujimoto, Takahiro Watanabe, Akira I Hida, Tomoko Higuchi, Yoshimasa Miyagawa, Reiko Fukui

Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
Hiromi Ozawa, Atsushi Sata, Reiko Fukui, Ayako Bun, Tomoko Higuchi

Anticancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Tomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, Ayako Bun, Reiko Fukui

Ann Surg Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.
Michiko Imamura, Takashi Morimoto, Chiyomi Egawa, Reiko Fukui, Ayako Bun

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
Makoto Ishitobi, Reiko Fukui, Yoko Hashimoto, Nobuyoshi Kittaka, Takahiro Nakayama

Oncology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
Makoto Ishitobi, Reiko Fukui, Yoko Hashimoto, Nobuyoshi Kittaka, Takahiro Nakayama

Anticancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucomannan utilization operon of Bacillus subtilis.
Yoshito Sadaie, Hisashi Nakadate, Reiko Fukui, Lii Mien Yee, Kei Asai

FEMS Microbiol Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis